Initially designed for treatment of myocardial infarction [26], GP IIb/IIIa inhibitors are nowadays widely used to prevent thromboembolic complications after emergency stenting for ischemic stroke treatment. The gene discussed is ITGA2B; the disease is ischemic stroke.